Cargando…
Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
The HMG-CoA reductase inhibitors, statins, have been used as lipid lowering drugs for decades and several epidemiological studies suggest statin usage correlates with a decreased incidence of cancer specific mortality in patients. However, the mechanism of this mortality benefit remains unclear. Her...
Autores principales: | Beckwitt, Colin H., Shiraha, Keisuke, Wells, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953490/ https://www.ncbi.nlm.nih.gov/pubmed/29763460 http://dx.doi.org/10.1371/journal.pone.0197422 |
Ejemplares similares
-
Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021) -
Statins attenuate outgrowth of breast cancer metastases
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics
por: Ishikawa, Takuro, et al.
Publicado: (2018) -
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
por: Warita, Katsuhiko, et al.
Publicado: (2014)